Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Perspectives on Behavior Science
|
September 23, 2024
Correction: Resurgence and Behavioral Contrast, Compared and Contrasted
Kennon A Lattal, Amanda K Miles
Journal of the Experimental Analysis of Behavior
|
November 20, 2025
Resurgence, behavioral contrast, and stimuli correlated with the absence of reinforcement
Amanda K Miles, Kennon A Lattal
Perspectives on Behavior Science
|
August 5, 2024
Resurgence and Behavioral Contrast, Compared and Contrasted
Kennon A Lattal, Amanda K Miles
Methods in Molecular Biology (Clifton, N.J.)
|
October 8, 2017
Generation of In Vitro Model of Epithelial Mesenchymal Transition (EMT) Via the Expression of a Cytoplasmic Mutant Form of Promylocytic Leukemia Protein (PML)
Anna Di Biase, Amanda K Miles, Tarik Regad
Cancer Immunology, Immunotherapy : CII
|
June 21, 2011
Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?
Naomi L Dunning, Stéphanie A Laversin, Amanda K Miles, et al.
Cancer Immunology, Immunotherapy : CII
|
January 13, 2006
The identification of human tumour antigens: Current status and future developments
Amanda K Miles, Balwir Matharoo-Ball, Geng Li, et al.
BJU International
|
August 20, 2011
Expression of the tumour antigen T21 is up-regulated in prostate cancer and is associated with tumour stage
Amanda K Miles, Alistair Rogers, Thomas McCulloch, et al.
The Journal of Biological Chemistry
|
March 7, 2012
The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo
Adam J Linley, Morgan G Mathieu, Amanda K Miles, et al.
Nutrients
|
May 16, 2019
Interscapular and Perivascular Brown Adipose Tissue Respond Differently to a Short-Term High-Fat Diet
Peter Aldiss, Michael E Symonds, Jo E Lewis, et al.
Proteomics. Clinical Applications
|
December 8, 2010
Diagnostic biomarkers differentiating metastatic melanoma patients from healthy controls identified by an integrated MALDI-TOF mass spectrometry/bioinformatic approach
Balwir Matharoo-Ball, Lucy Ratcliffe, Lee Lancashire, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Perspectives on Behavior Science
|
September 23, 2024
Correction: Resurgence and Behavioral Contrast, Compared and Contrasted
Kennon A Lattal, Amanda K Miles
Journal of the Experimental Analysis of Behavior
|
November 20, 2025
Resurgence, behavioral contrast, and stimuli correlated with the absence of reinforcement
Amanda K Miles, Kennon A Lattal
Perspectives on Behavior Science
|
August 5, 2024
Resurgence and Behavioral Contrast, Compared and Contrasted
Kennon A Lattal, Amanda K Miles
Methods in Molecular Biology (Clifton, N.J.)
|
October 8, 2017
Generation of In Vitro Model of Epithelial Mesenchymal Transition (EMT) Via the Expression of a Cytoplasmic Mutant Form of Promylocytic Leukemia Protein (PML)
Anna Di Biase, Amanda K Miles, Tarik Regad
Cancer Immunology, Immunotherapy : CII
|
June 21, 2011
Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?
Naomi L Dunning, Stéphanie A Laversin, Amanda K Miles, et al.
Cancer Immunology, Immunotherapy : CII
|
January 13, 2006
The identification of human tumour antigens: Current status and future developments
Amanda K Miles, Balwir Matharoo-Ball, Geng Li, et al.
BJU International
|
August 20, 2011
Expression of the tumour antigen T21 is up-regulated in prostate cancer and is associated with tumour stage
Amanda K Miles, Alistair Rogers, Thomas McCulloch, et al.
The Journal of Biological Chemistry
|
March 7, 2012
The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo
Adam J Linley, Morgan G Mathieu, Amanda K Miles, et al.
Nutrients
|
May 16, 2019
Interscapular and Perivascular Brown Adipose Tissue Respond Differently to a Short-Term High-Fat Diet
Peter Aldiss, Michael E Symonds, Jo E Lewis, et al.
Proteomics. Clinical Applications
|
December 8, 2010
Diagnostic biomarkers differentiating metastatic melanoma patients from healthy controls identified by an integrated MALDI-TOF mass spectrometry/bioinformatic approach
Balwir Matharoo-Ball, Lucy Ratcliffe, Lee Lancashire, et al.
Page
of 3